Open-label Phase 3 BTK Inhibitor Ibrutinib vs Chlorambucil Patients 65 Years or Older With Treatment-naive CLL or SLL
Clinical trial NCT01722487 · COMPLETED
Trial details
- NCT number
- NCT01722487
- Sponsor
- Pharmacyclics LLC.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2015-05-01
- Enrollment
- 269
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.